Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis. - Test2 - elhamkhani - TriplyDB

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

http://www.wikidata.org/entity/Q34154099

about

Immunoregulatory molecules are master regulators of inflammation during the immune response Indoleamine 2,3 dioxygenase in intestinal disease The microbiota and inflammatory bowel disease: insights from animal models Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia Bin1 attenuation suppresses experimental colitis by enforcing intestinal barrier function.The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis.Biomarkers in inflammatory bowel disease: current practices and recent advances.Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner.Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells.Severity of DSS-induced colitis is reduced in Ido1-deficient mice with down-regulation of TLR-MyD88-NF-kB transcriptional networks Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS).Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells.Intestinal CD103(+)CD11b(-) dendritic cells restrain colitis via IFN-γ-induced anti-inflammatory response in epithelial cells.Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis.IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice Indoleamine 2,3-dioxygenase: is it an immune suppressor?Toll-like receptor 9 agonists as cancer therapeutics.Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.Integrated stress response-altered pro-inflammatory signals in mucosal immune-related cells.Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis.Physiologic TLR9-CpG-DNA interaction is essential for the homeostasis of the intestinal immune system.Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model.Tissue metabolism and the inflammatory bowel diseases.Epithelial Histone Deacetylase 3 Instructs Intestinal Immunity by Coordinating Local Lymphocyte Activation.Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway.Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.N-(3', 4'-dimethoxycinnamonyl) anthranilic acid alleviated experimental colitis by inhibiting autoimmune response and inducing CD4+ CD25+ regulatory T cells production.Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice.Harnessing the Induction of CD8 T-Cell Responses Through Metabolic Regulation by Pathogen-Recognition-Receptor Triggering in Antigen Presenting Cells Downregulation of Interleukin- (IL-) 17 through Enhanced Indoleamine 2,3-Dioxygenase (IDO) Induction by Curcumin: A Potential Mechanism of Tolerance towards

P2860

Q27022027-742CAA30-D22B-46AB-897C-59F13789C52E Q27025063-699314F5-FA8D-4E94-B182-A462DDEA31A4 Q27027929-A557CF0D-FE69-4FEF-AEFF-33957DB8E0C8 Q33642585-6EC7CBC0-5E07-4E7A-9BF7-0F7827C6B8A2 Q33880455-5B7A1EBC-BE6E-4CD7-B808-FDCC4E812CEB Q33915720-71AF5E93-59BB-4D38-B47F-5D276D65F6EF Q34270337-A312044F-2186-49FE-9441-DDCDDE026892 Q34553267-91D7CC7B-327D-4543-B564-D8753D3B662B Q34776749-81E5B437-1C99-4C49-B818-D7123A2B7EDF Q35605835-2F45276A-B8FB-4C20-9707-FECC82E90412 Q35803149-CA2AEF83-55A5-44BA-AC69-4ADD1E296BD0 Q35840853-16E780AC-2758-4CB4-80AB-4C90EE2CA7EA Q35911231-4E17CA75-68AE-4FAD-9FC3-3FFC2EDF3597 Q35939274-0197CBC9-0AEE-4F52-A7BE-36B995E9CA12 Q35949475-856A1681-CCD5-4046-86AF-7BD4C10CDB7B Q36323786-6D731E5A-6E67-47BC-BFD2-F73198E1A70A Q36375050-4E1561BA-F20D-45C5-95B5-0C3603EC63AE Q36482311-06EE5262-7B09-4317-BF19-1FEEAAFADA79 Q36712480-D53631DB-CE85-4914-B079-6739443C256B Q36953989-F7A19AFF-73F8-49F0-BA8A-50D0165B5A26 Q37042990-8D11ACD1-3089-4242-8A8E-6A877D78B3D2 Q37362632-97349727-5C8C-4245-A7C4-0F1D0E42B752 Q37831323-3E1E1A75-A77B-4513-BA41-8C3720D46739 Q38047057-E4A98EB5-A7DC-43BD-8A7B-36C2DEB09ACE Q38067151-E3F1A6A7-C963-489D-A7F6-3673FC4A5D2A Q38118170-99D8F654-0E79-46BC-A6EB-2DB9E7709492 Q38311113-A474567A-657E-48B7-9C92-C775890766A0 Q38571347-D565AAFD-AE78-4789-84E5-CE89936E7910 Q38947206-5BDBAE40-30BD-401E-81B9-DEB28839EFE5 Q39320456-D1176FA0-038C-4368-A397-10ED3184812F Q40216623-E691A8AB-0BCF-409A-AEFF-17108E0DEC21 Q40385380-4F5E5D8A-5790-4CB7-95A1-088C124D0D96 Q41147895-F60E6634-FD57-42D1-AF0C-0F2B113F0106 Q42089828-5D9F6A21-2D5B-4F33-9324-64BA4106C30A Q48246344-F1050E71-CB2F-4B4E-A2A2-CAE6DD37CE0C Q50223024-F500905B-361D-4D15-8B28-50EC01F03948 Q51004185-75534541-4E37-4D1F-B13A-2B8F5EDD1137 Q53643579-C7047B97-21F0-4817-8C71-A93F2C34B09F Q58556287-4FAA8CDE-684F-4C8E-922D-B71B6A8E4F6D Q58580659-D4F493ED-EE9F-4147-84DF-4797D1014F30

P2860

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

http://www.wikidata.org/entity/Q34154099

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@ast

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@en

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@nl

type

label

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@ast

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@en

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@nl

prefLabel

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@ast

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@en

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@nl

P1433

Q34154099-CEBE1201-9ACE-4F20-BFFC-7579D34F5C17

P1476

Q34154099-1F80E781-FC14-4A88-AAFA-52E20F37DB86

P2093

Q34154099-0C855280-9ED8-4FF1-8E87-2B4BCE34A9B4

Q34154099-34C6771D-345F-42E7-A7F3-7BAD46EDCF64

Q34154099-7558ED6C-7BA1-477F-B7CB-7739A5F47BCD

Q34154099-A92B1F5C-4C38-42EF-A453-5D281E2CCFE1

Q34154099-B37EC17D-C30E-4CF5-87A4-3024B56F0D86

Q34154099-FE1D5B05-BA12-4A39-89B7-C0886BF75D19

P2860

Q34154099-119D17FC-DDDB-4B51-8860-C9EACA18D51A

Q34154099-1667AFA4-4452-4F77-8FF5-BEEC34654F38

Q34154099-17371382-163C-4109-91F6-53C91DB63459

Q34154099-19634DC7-ACAC-40CD-9684-6263797C08CA

Q34154099-197C021E-E06E-44EE-B5A7-3BF1C7A0078C

Q34154099-1AC1E034-940E-4969-9325-101F5E07E8B0

Q34154099-21F2201E-1AF2-421C-9932-B46E84185A03

Q34154099-2212682E-B050-4117-85EA-E0DDFA33F29B

Q34154099-22DC5DD1-1CF6-4878-AA39-E5E057427E0D

Q34154099-25930186-405B-49AC-A4D5-376E0A80D2D8

P304

Q34154099-E828B073-5D5F-4167-8CE9-D7E029277FD4

P31

Q34154099-12947C92-0713-4443-8566-3987A0886327

P356

Q34154099-C3F3393C-151D-4E35-A8FD-453EB1B7B78C

P407

Q34154099-697F4BDA-24DD-4740-B50C-37958842C1AD

P433

Q34154099-7A6D1CF7-AA48-42ED-A324-309FE77E8E16

P478

Q34154099-666601A0-876D-44BB-AD34-53C93E0EADFC

P50

Q34154099-76A2BB1E-FA46-4E13-9470-349200BAF6B3

P577

Q34154099-C473D565-F538-46E8-A9FF-1CA93445A6CB

P5875

Q34154099-6C37C37B-CE4E-4D8F-A665-26229B28854C

P698

Q34154099-EBEB045C-363B-4DF7-9D11-AC8E0B5E2092

P932

Q34154099-0FD90673-091C-414A-9F67-1BD69BA2EF48

P356

JIMMUNOL.0900291

P1433

Journal of Immunology

P1476

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

@en

P2093

Ellen E Bettonville

http://www.w3.org/2001/XMLSchema#string

George C Prendergast

http://www.w3.org/2001/XMLSchema#string

Keely G McDonald

http://www.w3.org/2001/XMLSchema#string

Matthew A Ciorba

http://www.w3.org/2001/XMLSchema#string

Richard Metz

http://www.w3.org/2001/XMLSchema#string

William F Stenson

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

Inhibition of T cell proliferation by macrophage tryptophan catabolism

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase

Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function

Unravelling the pathogenesis of inflammatory bowel disease

IDO expression by dendritic cells: tolerance and tryptophan catabolism

Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases.

IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.

P304

3907-3916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0900291

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P50

Rodney D. Newberry

P577

2010-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41562195

http://www.w3.org/2001/XMLSchema#string

P698

20181893

http://www.w3.org/2001/XMLSchema#string

P932

2945286

http://www.w3.org/2001/XMLSchema#string